Form 4: Chemed Corp Director Acquires Shares

Chemed Corp director Christopher J. Heaney acquired 386 shares of company stock on May 18, 2026, valued at $440.77 per share.

Summary

• Christopher J. Heaney, a Director at Chemed Corp, acquired 386 shares of the company's capital stock.
• The transaction occurred on May 18, 2026.
• The acquisition was made at a price of $440.77 per share.
• Following this transaction, Mr. Heaney beneficially owns 2,775 shares of Chemed Corp's capital stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine transaction by a director rather than significant financial results or strategic shifts.

Positives

• Director acquisition of shares can signal confidence in the company's future prospects.
• The acquisition was a direct purchase, indicating personal investment by a key insider.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that insider transactions, such as this share acquisition by a director, are closely watched by the market as potential indicators of management's view on the company's valuation and future performance within the healthcare and industrial services sectors where Chemed Corp operates.

Stakeholder Impact

• Shareholders may view this acquisition positively as a sign of insider confidence.
• Employees may interpret this as a stable outlook for the company.

Key Dates

Keywords

Chemed Corp, Form 4, Insider Trading, Share Acquisition, Director, Beneficial Ownership, SEC Filing